Drug Detail

Information about Gleevec + PEG-Intron

Generic Name	Imatinib + Peginterferon alfa-2b
IND	Imatinib + Pegylated Interferon-a 2B
Brand Name (US)	Gleevec + PEG-Intron
Manufacturer	Novartis, Schering
Drug Type
Delivery	Oral Subcutaneous
Approval Status	Both are approved. This combination is not approved for GIST. It was evaluated in a phase 2 trial for GIST.
Indications
Overall Strategy	GIST cell based KIT Protein Based
Strategy	Stimulate the immune system
Drug Category	KIT/PDGFRA inhibitor Immune stimulate

PEG-Intron is a long acting interferon. Interferons are proteins released in the body in response to viral infections. Interferons are important for fighting viruses in the body, for regulating reproduction of cells, and for regulating the immune system.

PEG-Intron is a specific interferon used to treat chronic hepatitis C.